Boussard & Gavaudan Investment Management’s Liberty Media Acquisition Corporation Series A Common Stock LMACA Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio LMACA Stock Details LMACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400,000	Closed	-$3.98K	–	156
2022 Q3	$3.98K	Hold	400,000	–	–	0.56%	45
2022 Q2	$3.93K	Hold	400,000	–	–	0.71%	41
2022 Q1	$3.97K	Buy	400,000 +115,731	+41%	+$1.16M	0.52%	33
2021 Q4	$2.92M	Buy	284,269 +81,020	+40%	+$831K	0.25%	64
2021 Q3	$2.05K	Buy	+203,249	New	+$2.07M	0.17%	68

Other funds holding LMACA

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boussard & Gavaudan Investment Management's LMACA Position: Q4 2022 in Review

Boussard & Gavaudan Investment Management sold out of Liberty Media Acquisition Corporation Series A Common Stock (LMACA) in Q4 2022, closing a stake of 400,000 shares — an estimated $3.98K sold.

Boussard & Gavaudan Investment Management first reported a position in LMACA in Q3 2021 and held it in 5 quarters. The position peaked at $2.92M in Q4 2021. 2 funds tracked by Wall St. Rank hold LMACA as of Q4 2022.

Boussard & Gavaudan Investment Management reported no remaining Liberty Media Acquisition Corporation Series A Common Stock position as of Q4 2022 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 400,000 Liberty Media Acquisition Corporation Series A Common Stock shares in Q4 2022, an estimated $3.98K.
Boussard & Gavaudan Investment Management first reported a position in Liberty Media Acquisition Corporation Series A Common Stock in Q3 2021 and held it in 5 quarters.
Boussard & Gavaudan Investment Management's Liberty Media Acquisition Corporation Series A Common Stock position peaked at $2.92M in Q4 2021.
2 funds tracked by Wall St. Rank held Liberty Media Acquisition Corporation Series A Common Stock as of Q4 2022.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.